ORION
1 known investors
Pareon Biosystems has developed a multiplex biomarker quantification method that produces absolute measurements with built-in correction for non-specific binding. The approach uses low concentrations of common reagents and standard lab equipment such as PCR, targeting personalized/precision medicine applications in research and clinical settings, including resource-limited environments.
Founders & leadership
GP
Guillaume ParéFounder & President
Investors · 1
Frequently asked questions
- What does ORION do?
- Pareon Biosystems has developed a multiplex biomarker quantification method that produces absolute measurements with built-in correction for non-specific binding. The approach uses low concentrations of common reagents and standard lab equipment such as PCR, targeting personalized/precision medicine applications in research and clinical settings, including resource-limited environments.
- Who founded ORION?
- ORION was founded by Guillaume Paré.
- Who are ORION's investors?
- ORION's investors include CABHI Ventures.